284 related articles for article (PubMed ID: 28293327)
1. The dynamic DNA methylation landscape of the
Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
[TBL] [Abstract][Full Text] [Related]
2. Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.
Savio AJ; Bapat B
Epigenetics; 2017 Jun; 12(6):441-448. PubMed ID: 28304185
[TBL] [Abstract][Full Text] [Related]
3. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals.
Savio AJ; Lemire M; Mrkonjic M; Gallinger S; Zanke BW; Hudson TJ; Bapat B
PLoS One; 2012; 7(12):e51531. PubMed ID: 23240038
[TBL] [Abstract][Full Text] [Related]
4. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
[TBL] [Abstract][Full Text] [Related]
5. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
[TBL] [Abstract][Full Text] [Related]
6. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
[TBL] [Abstract][Full Text] [Related]
7. Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
Mrkonjic M; Roslin NM; Greenwood CM; Raptis S; Pollett A; Laird PW; Pethe VV; Chiang T; Daftary D; Dicks E; Thibodeau SN; Gallinger S; Parfrey PS; Younghusband HB; Potter JD; Hudson TJ; McLaughlin JR; Green RC; Zanke BW; Newcomb PA; Paterson AD; Bapat B
PLoS One; 2010 Oct; 5(10):e13314. PubMed ID: 20967208
[TBL] [Abstract][Full Text] [Related]
8. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
[TBL] [Abstract][Full Text] [Related]
9. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.
Wong JJ; Hawkins NJ; Ward RL; Hitchins MP
Mod Pathol; 2011 Mar; 24(3):396-411. PubMed ID: 21102416
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.
Moreira L; Muñoz J; Cuatrecasas M; Quintanilla I; Leoz ML; Carballal S; Ocaña T; López-Cerón M; Pellise M; Castellví-Bel S; Jover R; Andreu M; Carracedo A; Xicola RM; Llor X; Boland CR; Goel A; Castells A; Balaguer F;
Cancer; 2015 May; 121(9):1395-404. PubMed ID: 25557234
[TBL] [Abstract][Full Text] [Related]
12. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.
Liu C; Fennell LJ; Bettington ML; Walker NI; Dwine J; Leggett BA; Whitehall VLJ
Clin Epigenetics; 2019 Jun; 11(1):90. PubMed ID: 31200767
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
[TBL] [Abstract][Full Text] [Related]
16. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
17. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
[TBL] [Abstract][Full Text] [Related]
19. MLH1-93G > A is a risk factor for MSI colorectal cancer.
Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
[TBL] [Abstract][Full Text] [Related]
20. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
Russell H; Kedzierska K; Buchanan DD; Thomas R; Tham E; Mints M; Keränen A; Giles GG; Southey MC; Milne RL; Tomlinson I; Church D; Spurdle AB; O'Mara TA; Lewis A
Clin Epigenetics; 2020 Jul; 12(1):102. PubMed ID: 32641106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
